Jump to content
  • Posts

    15
  • Joined

  • Last visited

Richard Jones

Members

Reputation

8 Novice

Profile Information

  • First name
    Richard
  • Last name
    Jones
  • Country
    United Kingdom

About me

  • About me
    C2-Ai is one of 10 Essential Digital Health Ideas for a UK National Covid Response according to Healthcare UK and could save 70,000 lives, £1bn and 2m bed-days across the NHS annually.

    Richard was a COGX keynote speaker on the Global Leadership stage and won (with C2 Ai) two awards including the prestigious Overall Tech4Covid award.

    With over 30 years spent in advanced technologies, Richard has extensive experience as an entrepreneur, in strategy development, business planning/modelling, and creating commercial implementations for companies. He has co-founded businesses across four continents that have delivered up to 300x returns on first round.

    He was the only private sector member of a national regulator’s synthetic AI patient record and medical AI software validation project. In addition to his work at C2-Ai, he holds positions in an Ai/High Performance Computing business, an Ai-based healthcare company, a stealth mode Ai start-up and telecoms businesses in the UK and Africa. He is the author of three business books translated into multiple languages.

    Richard received an MBA with distinction from the Warwick Business School and will be restarting a doctorate in technology strategy when he finds a spare moment or ten.
  • Organisation
    C2-Ai
  • Role
    President and Chief Strategy Officer

Recent Profile Visitors

2,167 profile views
  1. Community Post
    Thanks Theresa, Let me know what you think if there is anything you think if a bit off centre or really hits the mark. Regards Richard
  2. Community Post
    The assurance part is very complex indeed. The difference between deterministic and non-deterministic AI is fascinating. The non-deterministic is the greater challenge for regulation. I don't envy those trying to come up with effective solutions. A simple search on Google Bard on me suggests my MBA is from three different places in three different drafts. None are correct.
  3. Community Post
    The latest stat I heard is that each hospital generates more information than the Library of Congress. That is meant to store all media created (although I think that excludes Tik Tok videos and social media). I don't have a timescale for this but, if true, it's pretty impressive and also somewhat intimidating.
  4. Community Post
    I'm already seeing some of this come true with big payors in the US going off the idea of 'point solutions'. A lot of different concepts in here that will be unpacked in different ways in the next few months but what do you think? AI Hype versus Reality in Healthcare 20230803.pdf
  5. Community Post
    Projections indicate that there could be as much as 2,314 exabytes of new data generated in 2020. That’s 2,314 billion gigabytes of data. With a population of nearly 8 billion globally, that’s around 300 gigabytes of data per person per year. Is this realistic? How much of this data is being stored on phones and smartwatches, Fitbits etc.? So who has this data and how useful is it when it sits in a commercial company’s silo and does not complement health system’s own data? One simple truth - that volume of data requires collation, curation, contemplation (sorry - on an alliterative roll here).. but it really needs smart systems to convert it from data to wisdom. Are we on the right path or are we drowning in the data?
  6. Community Post
    If ice cream and dalmations are ever in a hospital context.. I want to be there.
  7. Community Post
    The classic dogs and muffins image has been beaten in my mind by this. How do you tell the diference between dalmations and ice cream? Imagine how hard this will be for AI. This level of find discrimination necessary is why AI is not easy.
  8. Community Post
    There are some companies working on the control of longitudinal patient records using blockchain. Can't believe I didn't drop that word in previously. Thanks for the thoughts. I'm generally aligned with your thoughts on use of my data.
  9. Community Post
    I think many of us in the industry are still wondering about access to data and who should have it. NHS Digital do a great job of protecting access to health records and as one of the companies that has earned the rigth to access the national records, I can say it is a very rigorous process to maintain that privilege. More broadly we are seeing companies get in trouble for using data in the wrong way from individual hospitals, non-anonymised records being shipped (by mistake) to a company and other things that citizens in some countries (I'm looking at friends in Sweden) would find unacceptable. So who owns your data? Are you happy for it to be sold or just passed on to companies, or do you want the opposite end of the spectrum where you have control over it and sharing beyond your direct health providers requires your consent (and maybe.. whisper it quietly.. payment). There is no one right answer but I'm fascinated by how we deal with data and a swing the door open policy and let favoured companies get access to it willy nilly doesn't seem like the smartest idea. But maybe I'm wrong...
  10. Community Post
    Absolutely. Also there is the rush to apply things at present which perhaps erodes some of the safety processes. Your point is why I was involved in a project to deliver synthetic data to then test software against a dataset that would highlight the efficacy or otherwise of the results.
  11. Article Comment
    Hi @Clive Flashman. I suspect many of us, when told not to look up an ailment online, do the exact opposite. The availability of information has changed in our lifetimes beyond all recognition. However, the quality of that information has also changed. Previously there were limited number of experts and now we have sources at our fingertips. The danger is with misinformation and an inability to know what is correct and what is not. The vaxxer/anti-vaxxer argument is perhaps a prime example or the use of bleach and other products to combat Covid-19. However, I think patient involvement in their own care is vital and if patients can't learn about illnesses etc. themselves, it is beholden on the clinicians to get them to a level of informed consent. I had a good experience recently where the doctor listened to my own ideas about how to deal with an issue and agreed it was sensible. The challenge will be to know what information is accurate and for clinicians to integrate that into discussions that are now done remotely in many cases and in time poor situations. I'd suggest that social media platforms are not the best place for an unbiased view on life and death matters though. There are plenty of websites that specialise in quality medical content that might be better choices for peer reviewed insights. Final thought, clinicians today are generally more friendly and open to discussion than in my younger days. The 'consultant is god' model seems to have gone but we're clearly not providing some patients with the darned good listening to that they need.
  12. Community Post
    I think there is potential to develop scenarios far quicker and more tailored to particular situations. So for example, you can create AI based images in bulk to show a clinician far more cases than they would normally see and build systems to keep people up to date and up to scratch. You can build subtler cases in bulk to help discrimination between different cases of an illness or disease. You can create synthetic data sets to test medical software and build in whatever bias you need to truly test something by packing the data with suitable case profiles while actual anonymised data may have only a handful. So there's lots of potential. But true AI software can modify itself and will not always give the same answer... so we need to be careful about the application and also remember the basics. Surgeon told me a story about a relative who had died and their x-ray. He asked the doctor who looked after his mother to comment on the x-ray which they did. Lots of comments on thumbprint marks etc. but actually completely failed to notice the name on the x-ray was not the name of the relative. It wasn't their x-ray. So as smart as we get.. we still need discipline and people like PSL helping staff set the right standards, do the right thing and be able to point out poor practice in a safe way.
  13. Community Post
    The wonderful team here at Patient Safety Learning think we need to talk about AI and the impact it can have on healthcare. So I'll be putting up a few topic starters in here but feel free to use this space and start your own conversations. AI means two things at the limit. It means software can change without instruction and the answers can sometimes change between a 'yes' or a 'no' for the same question. So how do we build safe, dependable applications that incorporate AI? How do we test them? How do we approve them? In the pandemic there is a rush to deploy solutions that is a commendable change of pace but at what cost? We should have authentic conversations here and I'm looking forward to discussing the topics above and many more with you. Ricahrd Jones
  14. Content Article
    As trusts consider clearing the waiting list, there is an absence of objective approaches to prioritisation. There are 40 million variations of operative type and the NHS elective waiting list may reach more than 10 million. A coronavirus second wave may cause further delays and expansion of the waiting list. This blog from hub topic lead Richard Jones describes a proven approach to prioritising the waiting list built around individualised risk-adjustment for each patient and evolved from the core POSSUM methodology that is widely used for individual risk assessment pre-operatively.
  15. Content Article Comment
    Great article and a very important topic Lorri. We have just been named as one of the '10 Digital Health Ideas for a UK National Covid-19 Response' by Healthcare UK (a joint initiative of NHS England, UK Departments of Health and International Trade) and it would be very good to discuss how patient safety approaches can make a big difference in the crisis. During the pandemic, we are deploying a risk-assessment tool, sythesized from our patient safety system and reductions in AKI of over 90% (publisihed approach in BJN and winning an HSJ Patient Safety Award) and HAP by 60%. Long story short is that those patients acquiring these conditions are blocking beds for up to 8 days extra on average. Those beds are needed for Covid-19 patients and so reducing these conditions is a critical part of the patient safety vision you've supported for so long Lorri. A 50% reduction in these conditions in US hospitals would free enough capacity for an extra 67,000 C-19 patients in the next 3 months. Could you find time for a discussion? AKI HAP Overivew 002.pdf
×
×
  • Create New...